These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 357068)

  • 1. Steady-state kinetics of valproic acid in epileptic patients.
    Bruni J; Wilder BJ; Willmore LJ; Perchalski RJ; Villarreal HJ
    Clin Pharmacol Ther; 1978 Sep; 24(3):324-32. PubMed ID: 357068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single and chronic dose pharmacokinetic studies of sodium valproate in epileptic patients.
    Mihaly GW; Vajda FJ; Miles JL; Louis WJ
    Eur J Clin Pharmacol; 1979 Aug; 16(1):23-9. PubMed ID: 387418
    [No Abstract]   [Full Text] [Related]  

  • 3. Single dose and steady state pharmacokinetics of valproic acid in adult epileptic patients.
    Miljković B; Pokrajac M; Varagić V; Lević Z
    Int J Clin Pharmacol Res; 1991; 11(3):137-41. PubMed ID: 1809700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Problems in serum-level determination during valproic acid therapy].
    Schäfer H; Reith H; Jacobs R; Gabriel KH
    Arzneimittelforschung; 1977; 27(6):1215-21. PubMed ID: 332187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose model for predicting steady-state valproic acid serum concentrations in seizure patients.
    Pugh CB; Garnett WR; Poynor WJ; Pellock JM
    Clin Pharm; 1984; 3(6):643-9. PubMed ID: 6439455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of valproic acid kinetics in patients during maintenance therapy using a tetradeuterated form of the drug.
    von Unruh GE; Jancik BC; Hoffman F
    Biomed Mass Spectrom; 1980 Apr; 7(4):164-7. PubMed ID: 6778521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diurnal variations in steady-state plasma concentrations of valproic acid in epileptic patients.
    Loiseau P; Cenraud B; Levy RH; Akbaraly R; Brachet-Liermain A; Guyot M; Morselli PL
    Clin Pharmacokinet; 1982; 7(6):544-52. PubMed ID: 6819106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of di-n-propylacetate in epileptic patients.
    Schobben F; van der Kleijn E; Gabreëls FJ
    Eur J Clin Pharmacol; 1975 Feb; 8(2):97-105. PubMed ID: 786678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of serum protein binding in epileptic children during sodium valproate maintenance therapy.
    Yu HY
    Ther Drug Monit; 1984; 6(4):414-23. PubMed ID: 6440321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid and simple gas-liquid chromatographic determination of valproic acid (alpha-propyl-valeric acid) in serum.
    Puukka M; Puukka R; Reunanen M
    J Clin Chem Clin Biochem; 1980 Aug; 18(8):497-9. PubMed ID: 6774050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbamazepine Verses Valproic Acid as Monotherapy in Epileptic Patients.
    Shakir S; Ali N; Nazish H
    J Coll Physicians Surg Pak; 2018 May; 28(5):357-360. PubMed ID: 29690963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of steady-state concentrations of valproic acid as determined from single plasma concentrations after the first dose.
    May CA; Garnett WR
    Clin Pharm; 1983; 2(2):143-7. PubMed ID: 6411412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inverse correlation of valproic acid serum concentrations and quality of life in adolescents with epilepsy.
    Jakovljevic MB; Jankovic SM; Jankovic SV; Todorovic N
    Epilepsy Res; 2008 Aug; 80(2-3):180-3. PubMed ID: 18495431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic monitoring of valproic acid.
    Schobben F; van der Kleijn E; Vree TB
    Ther Drug Monit; 1980; 2(1):61-71. PubMed ID: 6820201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of carnitine on the metabolism of valproic acid in epileptic patients.
    Sakemi K; Hayasaka K; Tahara M; Sanada Y; Takada G
    Tohoku J Exp Med; 1992 Jun; 167(2):89-92. PubMed ID: 1475789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of valproic acid in relation to plasma levels.
    Bruni J; Wilder BJ; Willmore LJ; Villarreal HJ; Thomas M; Crawford LE
    Can J Neurol Sci; 1978 Nov; 5(4):385-7. PubMed ID: 105796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steady-state valproate pharmacokinetics during long term therapy.
    Eadie MJ; Heazlewood V; McKauge L; Tyrer JH
    Clin Exp Neurol; 1983; 19():183-91. PubMed ID: 6439443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mg valproate plasma levels in epileptic patients, measured by gas-liquid chromatography (author's transl)].
    Saavedra I; Concha G; Valenzuela A; Galdames D; Aguilera L
    Rev Med Chil; 1981 Jan; 109(1):21-6. PubMed ID: 6791259
    [No Abstract]   [Full Text] [Related]  

  • 19. [Valproic acid serum through concentrations estimated from 12 hours post-dose concentrations in patients treated with Depakine® Crono].
    Lampón N; Tutor JC
    Farm Hosp; 2013; 37(1):79-80. PubMed ID: 23461508
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of ketogenic diet and other dietary therapies on anti-epileptic drug concentrations in patients with epilepsy.
    Heo G; Kim SH; Chang MJ
    J Clin Pharm Ther; 2017 Dec; 42(6):758-764. PubMed ID: 28626875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.